These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4025155)

  • 1. Electrophysiologic effects of amrinone.
    Goldstein RA; Gray EL; Dougherty AH; Naccarelli GV
    Am J Cardiol; 1985 Jul; 56(3):25B-28B. PubMed ID: 4025155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure.
    Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA
    Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction.
    Taylor SH; Verma SP; Hussain M; Reynolds G; Jackson NC; Hafizullah M; Richmond A; Silke B
    Am J Cardiol; 1985 Jul; 56(3):29B-32B. PubMed ID: 4025156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
    Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
    Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
    DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR
    J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amrinone on atrioventricular conduction in the intact canine heart.
    Nusrat A; Tepper D; Hertzberg J; Sonnenblick EH; Aronson RS
    J Clin Pharmacol; 1983 Jul; 23(7):257-65. PubMed ID: 6886027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
    Alousi AA; Canter JM; Fort DJ
    Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure.
    Silverman BD; Merrill AJ; Gerber L
    Arch Intern Med; 1985 May; 145(5):825-9. PubMed ID: 3994460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The improvement of cardiac performance by amrinone, a new cardiotonic drug, in an experimental failing heart preparation of the dog.
    Satoh K; Maruyama M; Taira N
    Jpn Heart J; 1982 Nov; 23(6):975-80. PubMed ID: 7161881
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
    Bottorff MB; Rutledge DR; Pieper JA
    Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amrinone in the management of low cardiac output after open heart surgery.
    Goenen M; Pedemonte O; Baele P; Col J
    Am J Cardiol; 1985 Jul; 56(3):33B-38B. PubMed ID: 4025158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic changes induced by amrinone in the isolated perfused guinea-pig Langendorff heart preparation.
    Onuaguluchi G; Tanz RD; McCawley E
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):263-73. PubMed ID: 6639219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D; LeJemtel T; Sonnenblick E
    Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.